KKR & Co. Inc. (NYSE:KKR) Shares Sold by Guggenheim Capital LLC

Guggenheim Capital LLC decreased its stake in KKR & Co. Inc. (NYSE:KKR - Free Report) by 62.2% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 17,904 shares of the asset manager's stock after selling 29,475 shares during the period. Guggenheim Capital LLC's holdings in KKR & Co. Inc. were worth $2,648,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently modified their holdings of the stock. Vanguard Group Inc. boosted its stake in KKR & Co. Inc. by 0.8% in the fourth quarter. Vanguard Group Inc. now owns 56,687,516 shares of the asset manager's stock valued at $8,384,650,000 after acquiring an additional 441,817 shares in the last quarter. Geode Capital Management LLC boosted its position in shares of KKR & Co. Inc. by 3.4% in the 4th quarter. Geode Capital Management LLC now owns 14,047,900 shares of the asset manager's stock valued at $2,073,624,000 after purchasing an additional 458,048 shares during the period. FMR LLC boosted its position in shares of KKR & Co. Inc. by 6.7% in the 4th quarter. FMR LLC now owns 12,003,389 shares of the asset manager's stock valued at $1,775,421,000 after purchasing an additional 752,056 shares during the period. Norges Bank purchased a new position in KKR & Co. Inc. during the 4th quarter worth approximately $1,435,314,000. Finally, Charles Schwab Investment Management Inc. increased its position in KKR & Co. Inc. by 2.3% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 3,772,331 shares of the asset manager's stock worth $557,965,000 after buying an additional 85,461 shares during the period. 76.26% of the stock is owned by hedge funds and other institutional investors.

KKR & Co. Inc. Stock Up 1.2 %

Shares of NYSE KKR opened at $103.29 on Friday. The stock has a market capitalization of $91.75 billion, a price-to-earnings ratio of 31.02, a price-to-earnings-growth ratio of 1.00 and a beta of 1.77. KKR & Co. Inc. has a 52 week low of $86.15 and a 52 week high of $170.40. The firm has a 50-day moving average price of $117.65 and a 200 day moving average price of $138.54. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.82.

KKR & Co. Inc. Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, February 28th. Stockholders of record on Friday, February 14th were given a dividend of $0.175 per share. The ex-dividend date was Friday, February 14th. This represents a $0.70 dividend on an annualized basis and a dividend yield of 0.68%. KKR & Co. Inc.'s payout ratio is 21.02%.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on KKR. Morgan Stanley lowered their target price on shares of KKR & Co. Inc. from $156.00 to $114.00 and set an "equal weight" rating on the stock in a research report on Monday, April 14th. Citigroup dropped their price objective on shares of KKR & Co. Inc. from $177.00 to $132.00 and set a "buy" rating on the stock in a research note on Tuesday, April 8th. Wells Fargo & Company decreased their target price on shares of KKR & Co. Inc. from $141.00 to $120.00 and set an "overweight" rating for the company in a research note on Tuesday, April 8th. JMP Securities dropped their price target on KKR & Co. Inc. from $165.00 to $150.00 and set a "market outperform" rating on the stock in a research report on Tuesday, April 8th. Finally, HSBC raised KKR & Co. Inc. from a "hold" rating to a "buy" rating and decreased their price objective for the stock from $170.00 to $119.00 in a research report on Tuesday, April 15th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating, fourteen have issued a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $144.93.

Insider Transactions at KKR & Co. Inc.

In related news, major shareholder Genetic Disorder L.P. Kkr sold 6,000,000 shares of the business's stock in a transaction dated Wednesday, March 5th. The shares were sold at an average price of $32.96, for a total value of $197,760,000.00. Following the sale, the insider now directly owns 19,260,971 shares in the company, valued at $634,841,604.16. The trade was a 23.75 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 39.34% of the company's stock.

About KKR & Co. Inc.

KKR & Co, Inc operates as an investment firm. It offers alternative asset management as well as capital markets and insurance solutions. The firm's business segments include Asset Management and Insurance Business. The Asset Management segment engages in providing private equity, real assets, credit and liquid strategies, capital markets, and principal activities.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.